Concord Biotech Limited (NSE:CONCORDBIO)

Concord Biotech Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 12, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	222,874	175,818	159,100	-	-	-
Market Cap Growth	10.51%	10.51%	-	-	-	-
Enterprise Value	219,727	173,015	157,079	-	-	-
Last Close Price	2130.40	1680.60	1512.33	-	-	-
PE Ratio	59.98	47.31	51.64	-	-	-
Forward PE	48.64	41.55	43.46	-	-	-
PS Ratio	18.57	14.65	15.65	-	-	-
PB Ratio	12.30	9.70	10.42	-	-	-
P/TBV Ratio	12.30	9.71	10.42	-	-	-
P/FCF Ratio	167.14	131.85	88.50	-	-	-
P/OCF Ratio	91.15	71.90	59.93	-	-	-
PEG Ratio	2.03	1.66	1.43	-	-	-
EV/Sales Ratio	18.31	14.42	15.45	-	-	-
EV/EBITDA Ratio	43.51	34.17	35.81	-	-	-
EV/EBIT Ratio	48.76	38.28	40.61	-	-	-
EV/FCF Ratio	164.78	129.75	87.37	-	-	-
Debt / Equity Ratio	0.00	0.00	0.01	0.02	0.06	0.09
Debt / EBITDA Ratio	0.01	0.01	0.02	0.09	0.22	0.27
Debt / FCF Ratio	0.02	0.02	0.05	0.31	1.19	-
Asset Turnover	0.64	0.64	0.63	0.60	0.57	0.58
Inventory Turnover	1.87	1.87	1.17	0.94	0.99	0.88
Quick Ratio	4.56	4.56	4.55	2.43	2.71	3.92
Current Ratio	6.17	6.17	6.31	3.79	4.08	5.74
Return on Equity (ROE)	22.26%	22.26%	21.88%	20.06%	16.64%	26.55%
Return on Assets (ROA)	15.13%	15.13%	15.04%	13.26%	11.47%	17.80%
Return on Capital (ROIC)	16.85%	16.85%	16.92%	15.07%	12.70%	19.78%
Return on Capital Employed (ROCE)	24.40%	24.40%	24.80%	22.70%	19.80%	28.10%
Earnings Yield	1.67%	2.11%	1.94%	-	-	-
FCF Yield	0.60%	0.76%	1.13%	-	-	-
Dividend Yield	0.51%	0.64%	0.58%	-	-	-
Payout Ratio	24.63%	24.63%	23.19%	22.31%	40.31%	2.43%
Buyback Yield / Dilution	-0.01%	-0.01%	-	-	-	-
Total Shareholder Return	0.50%	0.63%	0.58%	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.